Oculo-auricular syndrome caused by a novel HMX1 frameshift variant: a case report


Eser M., Yıldırım B. T.

Ophthalmic Genetics, cilt.47, sa.4, ss.425-427, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 4
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1080/13816810.2026.2635612
  • Dergi Adı: Ophthalmic Genetics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO)
  • Sayfa Sayıları: ss.425-427
  • Anahtar Kelimeler: Oculo-auricular syndrome, HMX1, novel variant
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Introduction: Oculo-auricular syndrome (OAS) is an extremely rare autosomal recessive disorder characterized by ocular anomalies and external ear malformations resulting from pathogenic HMX1 variants. In this study, we aimed to contribute to the literature by identifying a novel frameshift variant in the HMX1 gene. Materials and Methods: Genomic DNA was extracted from peripheral blood and analyzed by clinical exome sequencing using the SOPHiA DDM Clinical Exome Solution on an Illumina platform, with bioinformatic analysis performed according to ACMG guidelines. Identified variants were confirmed by Sanger sequencing using standard PCR amplification and capillary electrophoresis. Case Report: We describe a 5-year-3-month-old girl born to first-degree consanguineous parents, who previously underwent cataract surgery at 6 months of age. Clinical examination revealed iris coloboma, dysplastic ears including earlobe aplasia and hypoplastic helices, a high-arched palate. Clinical exome sequencing identified a novel homozygous frameshift variant in HMX1 (NM_018942.3:c.233_251dup, p.Ala85Argfs *53), which was confirmed by Sanger sequencing. Segregation analysis demonstrated heterozygous carrier status in the parents and healthy sibling. Discussion: In this study, a novel frameshift variant in the HMX1 gene was identified in a patient with oculo-auricular syndrome, thereby contributing to the literature and further highlighting the importance of molecular testing.